5UP0 image
Entry Detail
PDB ID:
5UP0
Title:
Crystal structure of human PDE1B catalytic domain in complex with inhibitor 3 (6-(4-chlorobenzyl)-8,9,10,11-tetrahydrobenzo[4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-one)
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2017-02-01
Release Date:
2017-04-26
Method Details:
Experimental Method:
Resolution:
2.04 Å
R-Value Free:
0.22
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 43 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B
Chain IDs:A
Chain Length:361
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation

Abstact

A series of potent thienotriazolopyrimidinone-based PDE1 inhibitors was discovered. X-ray crystal structures of example compounds from this series in complex with the catalytic domain of PDE1B and PDE10A were determined, allowing optimization of PDE1B potency and PDE selectivity. Reduction of hERG affinity led to greater than a 3000-fold selectivity for PDE1B over hERG. 6-(4-Methoxybenzyl)-9-((tetrahydro-2H-pyran-4-yl)methyl)-8,9,10,11-tetrahydropyrido[4',3':4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-one was identified as an orally bioavailable and brain penetrating PDE1B enzyme inhibitor with potent memory-enhancing effects in a rat model of object recognition memory.

Legend

Protein

Chemical

Disease

Primary Citation of related structures